Your browser doesn't support javascript.
loading
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
Darlow, Christopher A; McEntee, Laura; Johnson, Adam; Farrington, Nicola; Unsworth, Jennifer; Jimenez-Valverde, Ana; Jagota, Bhavana; Kolamunnage-Dona, Ruwanthi; Da Costa, Renata M A; Ellis, Sally; Franceschi, François; Sharland, Mike; Neely, Michael; Piddock, Laura; Das, Shampa; Hope, William.
Afiliação
  • Darlow CA; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
  • McEntee L; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
  • Johnson A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
  • Farrington N; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
  • Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
  • Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
  • Jagota B; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
  • Kolamunnage-Dona R; Department of Health Data Science, University of Liverpool, Liverpool Health Partners, Liverpool L69 3GF, UK.
  • Da Costa RMA; Global Antibiotic Research and Development Partnership, 15 Chemin Camille-Vidart, Geneva 1202, Switzerland.
  • Ellis S; Global Antibiotic Research and Development Partnership, 15 Chemin Camille-Vidart, Geneva 1202, Switzerland.
  • Franceschi F; Global Antibiotic Research and Development Partnership, 15 Chemin Camille-Vidart, Geneva 1202, Switzerland.
  • Sharland M; Paediatric Infectious Diseases Research Group, St George's University of London, London SW17 0QT, UK.
  • Neely M; Department of Infectious Diseases, Children's Hospital Los Angeles and the Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA.
  • Piddock L; Global Antibiotic Research and Development Partnership, 15 Chemin Camille-Vidart, Geneva 1202, Switzerland.
  • Das S; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
  • Hope W; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool L69 7BE, UK.
J Antimicrob Chemother ; 77(12): 3349-3357, 2022 11 28.
Article em En | MEDLINE | ID: mdl-36177766
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amicacina / Sepse Neonatal Limite: Humans / Infant / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amicacina / Sepse Neonatal Limite: Humans / Infant / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article